Sarah S P DiMagno1, Ezekiel J Emanuel1. Show Affiliations » 1. Department of Medical Ethics & Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Abstract
Mesh： See more » Antineoplastic AgentsCost-Benefit AnalysisDisease-Free SurvivalHumansIpilimumabMelanomaOncolytic Virotherapy
Substances： See more » Antineoplastic AgentsIpilimumab
Year: 2019 PMID： 30476974 DOI： 10.1001/jamadermatol.2018.3753
Source DB: PubMed Journal: JAMA Dermatol ISSN： 2168-6068 Impact factor: 10.282